Análisis de pacientes con COVID-19 con inmunosupresión y trasplante renal en México

Objective: To analyze the proportion of coviD-19 cases with immunosuppression, in-patient management, and renal transplantation in the country Methods: Descriptive study, it was carried out an analysis of public data bases about COVID-19 cases in Mexico until September, the proportion of hospitalized patients with immunosuppression who had a renal transplant, as well as their evolution was analyzed Results: Cases with coviD-19 and immunosuppression were 13, 285, 30 8% were attended in a hospital (4, 104) The condition of immunosuppression was 4% (166) due to the use of immune-modulators, in renal transplantation, in this group of in-patients;with a mortality rate of 41 5% (69) Conclusions: The mortality rate of in-patients with coviD-19 with immunosuppression due to the use of immune-modulators is four times higher when compared to the coviD-19 national mortality rate